Understanding PCOS and Hypothalamic AmenorrheaPolycystic ovarian syndrome (PCOS) is an endocrine disorder characterized by various signs: irregular periods, anovulation, high androgens, insulin resistance. Because it is a syndrome, it presents differently in every person. Two women might have PCOS and have completely different symptoms. The signs through which it is often diagnosed will also vary. […]
I am 26 years old and living in Switzerland. I work in marketing. I currently weigh only 62kg (136lbs) even though I am 184 cm (6 ft) tall. Two years ago, I developed a small intestinal bacterial overgrowth (SIBO) infection suddenly after taking 20g of a probiotic called Perfect Pass Prebiotic. It contains partially hydrolyzed […]
There is ever increasing evidence that energy metabolism is involved in the causation of cancer. A phenomenon known as the Warburg effect has been known for a century and was thought by Warburg to be the cause of cancer. To summarize this effect, normal cells primarily produce energy by the consumption of oxygen in a […]
I was prompted to write this article because of the recent bad news that Kelly Preston had died of breast cancer at 57. She leaves behind a son who is just 9 – and a grieving family. She is just two years younger than I am.I find myself sitting here, and wondering: did she try […]
In addition to the adverse event of dizziness reported during and post Lupron use, just reading and trying to understand Lupron’s literature can also be dizzying. So much of the research and information about this drug is utterly baffling; some circumstances have been manipulated by slick design, with information hidden or suppressed, other Lupron information […]
Recent attention in a dual Reveal and Kaiser Health News Report (‘Kaiser Report’) to the risks of Lupron’s use in children with central precocious puberty (PP) or growth issues, and to Lupron’s risks in general, presents an opportunity to continue the disclosures on the risks of Lupron. This is the fifth part in a 6-part […]
Recent attention in a dual Reveal and Kaiser Health News Report to the risks of Lupron’s use in children with central precocious puberty (PP) or growth issues, and to Lupron’s risks in general, presents an opportunity to continue the disclosures on the risks of Lupron. This is the fourth part in a 6-week series exploring numerous areas addressing the […]
Recent attention in a dual Reveal and Kaiser Health News Report (‘Kaiser Report’) to the risks of Lupron’s use in children with central precocious puberty or growth issues, and to Lupron’s risks in general, presents an opportunity to continue the disclosures on the risks of Lupron. This is the third part in a 6-week series […]